Sica A, Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest. 2007, 117: 1155-1166. 10.1172/JCI31422.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S: Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol. 2007, 179: 977-983.
Article
CAS
PubMed
Google Scholar
Zou W: Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006, 6: 295-307. 10.1038/nri1806.
Article
CAS
PubMed
Google Scholar
Gabrilovich DI, Nagaraj S: Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009, 9: 162-174. 10.1038/nri2506.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greten TF, Manns MP, Korangy F: Myeloid derived suppressor cells in human diseases. Int Immunopharmacol. 2011, 11: 802-807. 10.1016/j.intimp.2011.01.003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Peranzoni E, Zilio S, Marigo I, Dolcetti L, Zanovello P, Mandruzzato S, Bronte V: Myeloid-derived suppressor cell heterogeneity and subset definition. Curr Opin Immunol. 2010, 22: 238-244. 10.1016/j.coi.2010.01.021.
Article
CAS
PubMed
Google Scholar
Gallina G, Dolcetti L, Serafini P, De Santo C, Marigo I, Colombo MP, Basso G, Brombacher F, Borrello I, Zanovello P, Bicciato S, Bronte V: Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest. 2006, 116: 2777-2790. 10.1172/JCI28828.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI: Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med. 2007, 13: 828-835. 10.1038/nm1609.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI: Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. J Immunol. 2010, 184: 3106-3116. 10.4049/jimmunol.0902661.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu C, Yu S, Kappes J, Wang J, Grizzle WE, Zinn KR, Zhang HG: Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood. 2007, 109: 4336-4342. 10.1182/blood-2006-09-046201.
Article
CAS
PubMed
PubMed Central
Google Scholar
Suzuki E, Kapoor V, Jassar AS, Kaiser LR, Albelda SM: Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res. 2005, 11: 6713-6721. 10.1158/1078-0432.CCR-05-0883.
Article
CAS
PubMed
Google Scholar
Nagaraj S, Nelson A, Youn JI, Cheng P, Quiceno D, Gabrilovich DI: Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res. 2012, 72: 928-938. 10.1158/0008-5472.CAN-11-2863.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bronte V, Zanovello P: Regulation of immune responses by L-arginine metabolism. Nat Rev Immunol. 2005, 5: 641-654. 10.1038/nri1668.
Article
CAS
PubMed
Google Scholar
Gabrilovich DI, Ostrand-Rosenberg S, Bronte V: Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012, 12: 253-268. 10.1038/nri3175.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ugel S, Peranzoni E, Desantis G, Chioda M, Walter S, Weinschenk T, Ochando JC, Cabrelle A, Mandruzzato S, Bronte V: Immune tolerance to tumor antigens occurs in a specialized environment of the spleen. Cell Rep. 2012, 2: 628-639. 10.1016/j.celrep.2012.08.006.
Article
CAS
PubMed
Google Scholar
Pan PY, Ma G, Weber KJ, Ozao-Choy J, Wang G, Yin B, Divino CM, Chen SH: Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. Cancer Res. 2010, 70: 99-108. 10.1158/0008-5472.CAN-09-1882.
Article
CAS
PubMed
PubMed Central
Google Scholar
Serafini P, Mgebroff S, Noonan K, Borrello I: Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells. Cancer Res. 2008, 68: 5439-5449. 10.1158/0008-5472.CAN-07-6621.
Article
CAS
PubMed
PubMed Central
Google Scholar
Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI: HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010, 207: 2439-2453. 10.1084/jem.20100587.
Article
CAS
PubMed
PubMed Central
Google Scholar
Doedens AL, Stockmann C, Rubinstein MP, Liao D, Zhang N, DeNardo DG, Coussens LM, Karin M, Goldrath AW, Johnson RS: Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 2010, 70: 7465-7475. 10.1158/0008-5472.CAN-10-1439.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kodumudi KN, Woan K, Gilvary DL, Sahakian E, Wei S, Djeu JY: A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. Clin Cancer Res. 2010, 16: 4583-4594. 10.1158/1078-0432.CCR-10-0733.
Article
CAS
PubMed
Google Scholar
Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D: All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Res. 2003, 63: 4441-4449.
CAS
PubMed
Google Scholar
Mirza N, Fishman M, Fricke I, Dunn M, Neuger AM, Frost TJ, Lush RM, Antonia S, Gabrilovich DI: All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Res. 2006, 66: 9299-9307. 10.1158/0008-5472.CAN-06-1690.
Article
CAS
PubMed
PubMed Central
Google Scholar
Shirota Y, Shirota H, Klinman DM: Intratumoral injection of CpG oligonucleotides induces the differentiation and reduces the immunosuppressive activity of myeloid-derived suppressor cells. J Immunol. 2012, 188: 1592-1599. 10.4049/jimmunol.1101304.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fernandez A, Mesa C, Marigo I, Dolcetti L, Clavell M, Oliver L, Fernandez LE, Bronte V: Inhibition of tumor-induced myeloid-derived suppressor cell function by a nanoparticulated adjuvant. J Immunol. 2011, 186: 264-274. 10.4049/jimmunol.1001465.
Article
CAS
PubMed
Google Scholar
Ohkusu-Tsukada K, Ohta S, Kawakami Y, Toda M: Adjuvant effects of formalin-inactivated HSV through activation of dendritic cells and inactivation of myeloid-derived suppressor cells in cancer immunotherapy. Int J Cancer. 2011, 128: 119-131. 10.1002/ijc.25319.
Article
CAS
PubMed
Google Scholar
Estevez F, Carr A, Solorzano L, Valiente O, Mesa C, Barroso O, Sierra GV, Fernandez LE: Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP). Vaccine. 1999, 18: 190-197. 10.1016/S0264-410X(99)00219-4.
Article
CAS
PubMed
Google Scholar
Mesa C, de Leon J, Fernandez LE: Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for generation of CTL responses to peptide and protein antigens. Vaccine. 2006, 24: 2692-2699. 10.1016/j.vaccine.2005.08.111.
Article
CAS
PubMed
Google Scholar
Mesa C, De Leon J, Rigley K, Fernandez LE: Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for Th1 induction and dendritic cell activation. Vaccine. 2004, 22: 3045-3052. 10.1016/j.vaccine.2004.02.010.
Article
CAS
PubMed
Google Scholar
Oliver L, Fernandez A, Raymond J, Lopez-Requena A, Fernandez LE, Mesa C: Very small size proteoliposomes derived from Neisseria meningitidis: an effective adjuvant for antigen-specific cytotoxic T lymphocyte response stimulation under leukopenic conditions. Vaccine. 2012, 30: 2963-2972. 10.1016/j.vaccine.2012.02.054.
Article
CAS
PubMed
Google Scholar
Ramirez BS, Pestana ES, Hidalgo GG, Garcia TH, Rodriguez RP, Ullrich A, Fernandez LE: Active antimetastatic immunotherapy in Lewis lung carcinoma with self EGFR extracellular domain protein in VSSP adjuvant. Int J Cancer. 2006, 119: 2190-2199. 10.1002/ijc.22085.
Article
PubMed
Google Scholar
Bequet-Romero M, Morera Y, Ayala-Avila M, Ancizar J, Soria Y, Blanco A, Suarez-Alba J, Gavilondo JV: CIGB-247: a VEGF-based therapeutic vaccine that reduces experimental and spontaneous lung metastasis of C57Bl/6 and BALB/c mouse tumors. Vaccine. 2012, 30: 1790-1799. 10.1016/j.vaccine.2012.01.006.
Article
CAS
PubMed
Google Scholar
Solares AM, Baladron I, Ramos T, Valenzuela C, Borbon Z, Fanjull S, Gonzalez L, Castillo D, Esmir J, Granadillo M, Batte A, Cintado A, Ale M, de Cossio ME F, Ferrer A, Torrens I, Lopez-Saura P: Safety and Immunogenicity of a human papillomavirus peptide vaccine (CIGB-228) in women with high-grade cervical intraepithelial neoplasia: first-in-human, Proof-of-Concept Trial. ISRN Obstet Gynecol. 2011, 2011: 292951-
Article
PubMed
PubMed Central
Google Scholar
Aguilar FF, Barranco JJ, Fuentes EB, Aguilera LC, Saez YL, Santana MD, Vazquez EP, Baker RB, Acosta OR, Perez HG, Nieto GG: Very small size proteoliposomes (VSSP) and Montanide combination enhance the humoral immuno response in a GnRH based vaccine directed to prostate cancer. Vaccine. 2012, 30: 6595-6599. 10.1016/j.vaccine.2012.08.020.
Article
CAS
PubMed
Google Scholar
Public Register of Cuban Clinical Trials. [http://rpcec.sld.cu/]
Hanson EM, Clements VK, Sinha P, Ilkovitch D, Ostrand-Rosenberg S: Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells. J Immunol. 2009, 183: 937-944. 10.4049/jimmunol.0804253.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rodriguez PC, Zea AH, Culotta KS, Zabaleta J, Ochoa JB, Ochoa AC: Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem. 2002, 277: 21123-21129. 10.1074/jbc.M110675200.
Article
CAS
PubMed
Google Scholar
Kruisbeek AM, Shevach E, Thornton AM: Proliferative assays for T cell function. Curr Protoc Immunol. 2004, Chapter 3: Unit 3 12-
PubMed
Google Scholar
Talmadge JE, Gabrilovich DI: History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013, 13: 739-752. 10.1038/nrc3581.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rodriguez PC, Quiceno DG, Zabaleta J, Ortiz B, Zea AH, Piazuelo MB, Delgado A, Correa P, Brayer J, Sotomayor EM, Antonia S, Ochoa JB, Ochoa AC: Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res. 2004, 64: 5839-5849. 10.1158/0008-5472.CAN-04-0465.
Article
CAS
PubMed
Google Scholar
Schmielau J, Finn OJ: Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 2001, 61: 4756-4760.
CAS
PubMed
Google Scholar
Michels T, Shurin GV, Naiditch H, Sevko A, Umansky V, Shurin MR: Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner. J Immunotoxicol. 2012, 9: 292-300. 10.3109/1547691X.2011.642418.
Article
CAS
PubMed
PubMed Central
Google Scholar
Greifenberg V, Ribechini E, Rossner S, Lutz MB: Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development. Eur J Immunol. 2009, 39: 2865-2876. 10.1002/eji.200939486.
Article
CAS
PubMed
Google Scholar
Zoglmeier C, Bauer H, Norenberg D, Wedekind G, Bittner P, Sandholzer N, Rapp M, Anz D, Endres S, Bourquin C: CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice. Clin Cancer Res. 2011, 17: 1765-1775. 10.1158/1078-0432.CCR-10-2672.
Article
CAS
PubMed
Google Scholar
Condamine T, Gabrilovich DI: Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 2011, 32: 19-25. 10.1016/j.it.2010.10.002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chalmin F, Ladoire S, Mignot G, Vincent J, Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau D, De Thonel A, Multhoff G, Hamman A, Martin F, Chauffert B, Solary E, Zitvogel L, Garrido C, Ryffel B, Borg C, Apetoh L, Rebe C, Ghiringhelli F: Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells. J Clin Invest. 2010, 120: 457-471.
CAS
PubMed
PubMed Central
Google Scholar
Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999, 223: 77-92. 10.1016/S0022-1759(98)00204-X.
Article
CAS
PubMed
Google Scholar